Form D · Biotechnology

Shattuck Labs, Inc.

Austin, TX · CIK 0001680367

Offering snapshot reported Jun 23, 2020 · SEC filing

Reported sold
$83M
Offering amount: $83M
Investors reported
32
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 12, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 23, 2020Initial$83,000,009No comparison32SEC filing
Feb 13, 2020Initial$25,379,957No comparison71SEC filing
May 25, 2018Initial$46,618,910No comparison62SEC filing
Apr 5, 2017Initial$7,000,000No comparison27SEC filing
Aug 22, 2016Amendment$3,400,826$1,675,000vs Jul 28, 201625SEC filing
Jul 28, 2016Initial$1,725,826No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-369518

Source: Form D, filed Jun 23, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tyler Brous Director
Charles Dorrance Director
Neil Gibson Director
George Golumbeski Director
Charles Golumbeski Director
Josiah Hornblower Director
Chris Hurff Director
Mike Lee Director
G. Walter Loewenbaum Director
Walter Loewenbaum Director
David G. Lowe Director
Taylor Schreiber Director, Executive
Victor Stone Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1018 W. 11 Th Street
Austin, TX, 78703